Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025BiomedicinesOpen Access

Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHubert BorzutaWKWiktor KociembaOBOliwia Bochenek

Discussion

Loading...

Member takes

Overview

Literature review highlights pathophysiological mechanisms and current therapeutic strategies for coronary no-reflow in STEMI patients, suggesting new treatment avenues.

Key Points

  • Coronary no-reflow (CNR) complicates treatment for patients with ST-segment elevation myocardial infarction (STEMI), increasing mortality rates.
  • Pathophysiological factors contributing to CNR include myocardial ischemia, endothelial damage, and reactive oxygen species (ROS) production.
  • Contemporary treatment approaches for CNR are limited to pharmacological therapies, emphasizing the need for novel strategies.
  • Understanding CNR's mechanisms presents opportunities for improving therapies and reducing adverse cardiac events in affected patients.

Cite This Study

Borzuta et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc742https://doi.org/10.3390/biomedicines13071716
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1No Reflow-phenomenon: from Current State of the Art to Future Perspectives2015 · 1 citations
  2. 2Practical Approach to Diagnosis, Prevention, and Management of Coronary No-Reflow2023 · 1 citations
  3. 3Coronary Microcirculation and the No-reflow Phenomenon2018 · 28 citations
  4. 4Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon2022 · 10 citations
  5. 5Prevention and Treatment of No-Reflow Phenomenon by Targeting the Coronary Microcirculation2014 · 37 citations